April SAS-B figures: pastilles hit nearly one-third of approvals by Adam Sheldon May 7, 2026May 7, 2026 Approvals through the Special Access Scheme fell below 20,000 in April, as pastilles continued to cement […]
Prominent prescriber faces lifetime ban after AHPRA investigation by Adam Sheldon November 13, 2025November 17, 2025
